These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1451121)
1. Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography. Schumacher M; Eber B; Tiran A; Toplak H; Luha O; Gasser R; Klein W Cardiology; 1992; 80(5-6):345-8. PubMed ID: 1451121 [TBL] [Abstract][Full Text] [Related]
3. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty. Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431 [TBL] [Abstract][Full Text] [Related]
4. [Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis]. Ishikawa Y; Fujioka Y; Kitagawa Y; Nobusawa A; Takahashi A; Taniguchi T; Yokoyama M Nihon Ronen Igakkai Zasshi; 1995 Jul; 32(7):491-6. PubMed ID: 7500552 [TBL] [Abstract][Full Text] [Related]
5. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina]. Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease. Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526 [TBL] [Abstract][Full Text] [Related]
7. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872 [TBL] [Abstract][Full Text] [Related]
8. [Normalization of lipid metabolism disturbances and clinical course after percutaneous coronary angioplasty: 6 month observation]. Ochała A; Gabrylewicz B; Bartnik M; Garbocz P; Wycisk A; Lewicki A; Kaźmierski M; Tendera M Pol Arch Med Wewn; 2000 Dec; 104(6):833-41. PubMed ID: 11424662 [TBL] [Abstract][Full Text] [Related]
9. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. Benchimol D; Bonnet J; Benchimol H; Drouillet F; Duplaa C; Couffinhal T; Desgranges C; Bricaud H Int J Cardiol; 1993 Jan; 38(1):7-18. PubMed ID: 8444504 [TBL] [Abstract][Full Text] [Related]
10. Serum lipids and restenosis after successful percutaneous transluminal coronary angioplasty. Ichilov Magnesium Study Group. Roth A; Eshchar Y; Keren G; Sheps D; Kerbal S; Laniado S; Miller HI; Rubinstein A Am J Cardiol; 1994 Jun; 73(16):1154-8. PubMed ID: 8203331 [TBL] [Abstract][Full Text] [Related]
11. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty. Johansson SR; Wiklund O; Karlsson T; Hjalmarson A; Emanuelsson H Eur Heart J; 1991 Sep; 12(9):1020-8. PubMed ID: 1936002 [TBL] [Abstract][Full Text] [Related]
12. [Rate of restenosis after PTCA in patients with terminal renal failure. A quantitative coronary angiography study]. Gradaus F; Schoebel FC; Ivens K; Jax TW; Heering P; Strauer BE; Leschke M Z Kardiol; 1997 May; 86(5):373-9. PubMed ID: 9304313 [TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA? Kanemitsu S; Takekoshi N; Matsui S; Tsugawa H; Ohkubo S; Kitayama M; Matsuda T; Senma J; Masuyama K; Yamagata T; Murakami E Ther Apher; 1998 Feb; 2(1):65-70. PubMed ID: 10227791 [TBL] [Abstract][Full Text] [Related]
14. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). DeMaio SJ; King SB; Lembo NJ; Roubin GS; Hearn JA; Bhagavan HN; Sgoutas DS J Am Coll Nutr; 1992 Feb; 11(1):68-73. PubMed ID: 1541798 [TBL] [Abstract][Full Text] [Related]
15. Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables. Johansen O; Abdelnoor M; Brekke M; Seljeflot I; Høstmark AT; Arnesen H Scand Cardiovasc J; 2001 Mar; 35(2):86-91. PubMed ID: 11405502 [TBL] [Abstract][Full Text] [Related]
16. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty]. Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674 [TBL] [Abstract][Full Text] [Related]
17. [Preventive effect of pravastatin on restenosis following coronary angioplasty: prospective randomized trial]. Iwasaki K; Kusachi S; Hina K; Yamasaki S; Nishiyama O; Takaishi A; Kita T; Taniguchi G J Cardiol; 1995 Jan; 25(1):15-21. PubMed ID: 7877098 [TBL] [Abstract][Full Text] [Related]
18. Influence of continued smoking and some biological risk factors on restenosis after percutaneous transluminal coronary angioplasty. Kotamäki M; Laustiola K; Syvänne M; Heikkilä J J Intern Med; 1996 Nov; 240(5):293-301. PubMed ID: 8946812 [TBL] [Abstract][Full Text] [Related]
19. The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty. Tenda K; Saikawa T; Maeda T; Sato Y; Niwa H; Inoue T; Yonemochi H; Maruyama T; Shimoyama N; Aragaki S Jpn Circ J; 1993 Aug; 57(8):789-95. PubMed ID: 8355396 [TBL] [Abstract][Full Text] [Related]